Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Mannaioni

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1995
NMDA receptor heterogeneity in mammalian tissues: focus on two agonists, (2S,3R,4S) cyclopropylglutamate and the sulfate ester of 4-hydroxy-(S)-pipecolic acidF Moroni, A Galli, G Mannaioni, et al.
European Review for Medical and Pharmacological Sciences|April 1, 2022
Equianalgesia, opioid switch and opioid association in different clinical settings: a narrative reviewF De Iaco, G Mannaioni, S Serra, et al.
Advances in Experimental Medicine and Biology|March 18, 2000
Tryptophan metabolism and hepatic encephalopathy. Studies on the sedative properties of oxindoleG Mannaioni, R Carpenedo, R Corradetti, et al.
Neurobiology of Disease|June 24, 2014
PARP-1 activation causes neuronal death in the hippocampal CA1 region by increasing the expression of Ca(2+)-permeable AMPA receptorsE Gerace, A Masi, F Resta, et al.
Scientific Reports|June 10, 2017
Optical mapping of neuronal activity during seizures in zebrafishL Turrini, C Fornetto, G Marchetto, et al.
Neuropharmacology|November 17, 2021
Moderate ethanol drinking is sufficient to alter Ventral Tegmental Area dopamine neurons activity via functional and structural remodeling of GABAergic transmissionA Ilari, L Curti, M Petrella, et al.
Neuropharmacology|January 18, 2018
Selective HCN1 block as a strategy to control oxaliplatin-induced neuropathyF Resta, L Micheli, A Laurino, et al.
Pharmacological Research|August 20, 2022
Acute rapamycin rescues the hyperexcitable phenotype of accumbal medium spiny neurons in the valproic acid rat model of autism spectrum disorderD Iezzi, L Curti, G Ranieri, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 12, 2025
The dual role of VEGF-A in a complex in vitro model of oxaliplatin-induced neurotoxicity: Pain-related and neuroprotective effectsA Toti, E Lucarini, V Ferrara, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1995
NMDA receptor heterogeneity in mammalian tissues: focus on two agonists, (2S,3R,4S) cyclopropylglutamate and the sulfate ester of 4-hydroxy-(S)-pipecolic acidF Moroni, A Galli, G Mannaioni, et al.
European Review for Medical and Pharmacological Sciences|April 1, 2022
Equianalgesia, opioid switch and opioid association in different clinical settings: a narrative reviewF De Iaco, G Mannaioni, S Serra, et al.
Advances in Experimental Medicine and Biology|March 18, 2000
Tryptophan metabolism and hepatic encephalopathy. Studies on the sedative properties of oxindoleG Mannaioni, R Carpenedo, R Corradetti, et al.
Neurobiology of Disease|June 24, 2014
PARP-1 activation causes neuronal death in the hippocampal CA1 region by increasing the expression of Ca(2+)-permeable AMPA receptorsE Gerace, A Masi, F Resta, et al.
Scientific Reports|June 10, 2017
Optical mapping of neuronal activity during seizures in zebrafishL Turrini, C Fornetto, G Marchetto, et al.
Neuropharmacology|November 17, 2021
Moderate ethanol drinking is sufficient to alter Ventral Tegmental Area dopamine neurons activity via functional and structural remodeling of GABAergic transmissionA Ilari, L Curti, M Petrella, et al.
Neuropharmacology|January 18, 2018
Selective HCN1 block as a strategy to control oxaliplatin-induced neuropathyF Resta, L Micheli, A Laurino, et al.
Pharmacological Research|August 20, 2022
Acute rapamycin rescues the hyperexcitable phenotype of accumbal medium spiny neurons in the valproic acid rat model of autism spectrum disorderD Iezzi, L Curti, G Ranieri, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 12, 2025
The dual role of VEGF-A in a complex in vitro model of oxaliplatin-induced neurotoxicity: Pain-related and neuroprotective effectsA Toti, E Lucarini, V Ferrara, et al.
Pageof 2